← Open Payments lookup

DEREK ANDRZEJEWSKI: Open Payments

NPI 1437785268 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,686 in 158 payments from 25 companies in 2025. Trend: 2023 $2,907 · 2024 $3,112 · 2025 $3,686

Food & beverage: $3,686
CompanyPaymentsAmount
GENZYME CORPORATION15$483
AstraZeneca Pharmaceuticals LP17$403
GlaxoSmithKline, LLC.25$365
PFIZER INC.14$305
Regeneron Healthcare Solutions, Inc.14$304
Novartis Pharmaceuticals Corporation12$260
Amgen Inc.14$247
Ionis Pharmaceuticals, Inc.7$221
Galderma Laboratories, L.P.7$202
CSL Behring5$137

Products named: DUPIXENT, TEZSPIRE, NUCALA, NEMLUVIO, DAWNZERA, AYVAKIT, FASENRA, CIBINQO.

Industry payments across WA — which companies pay providers there.